electroCore to Participate in Upcoming Investor Conferences ROCKAWAY, N.J., Sept. 26, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the following investor events: October 1 - Management will participate in one-on-one meetings at the October 17 -- Management will participate in a fireside chat with Anthony Vendetti, the Director of Research and Senior Healthcare Analyst, at the October 29 - Management will participate in one-on-one meetings, and host a grou...
electroCore Engages FNK IR to Execute Expanded Investor Relations Program ROCKAWAY, N.J., Sept. 24, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it has engaged FNK IR, an institutionally focused investor relations consulting firm, to develop and deploy an expanded outreach and communications program. Dan Goldberger, Chief Executive Officer of electroCore, commented, “electroCore has demonstrated strong financial performance, delivering seven consecutive quarters of record revenue and dr...
OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development WESTON, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health, Inc. (NASDAQ: OPK) company, today announced the appointment of Giovanni Abbadessa, M.D., Ph.D. as Chief Medical Officer, a newly created position. Dr. Abbadessa has over two decades of experience in drug development, including most recently as Vice President at Sanofi, where he provided executive leadership for advancing oncology assets. “Dr. Abbadessa’s deep ...
Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot Training Clinical trial demonstrates the ability of nVNS to accelerate sensorimotor learning in USAF Simulator Based Pilot Training ROCKAWAY, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that the Air Force Research Laboratories (AFRL) presented new results supporting the ability of electroCore’s TAC-STIM (nVNS) to accelerate pilot training. The presentation title...
Ryman Hospitality Properties, Inc. Provides Investor Presentation Ahead of the Bank of America Securities 2024 Global Real Estate Conference NASHVILLE, Tenn., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE: RHP) (the “Company”), a leading lodging and hospitality real estate investment trust that specializes in upscale convention center resorts and entertainment experiences, today provided an updated investor presentation ahead of its participation in the Bank of America Securities 2024 Global Real Estate Conference. The presentation can be found on the Investo...
Ryman Hospitality Properties, Inc. Announces Third Quarter 2024 Earnings Conference Call – Tuesday, November 5, 2024, 11 a.m. ET NASHVILLE, Tenn., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE: RHP) (the "Company”), a leading lodging and hospitality real estate investment trust that specializes in upscale convention center resorts and entertainment experiences, announced today that it will release its third quarter 2024 earnings results after the market closes on Monday, November 4, 2024. Management will hold a conference call to discuss the quarter's results...
Ryman Hospitality Properties, Inc. Declares Third Quarter Dividend and Corrects Methodology for Calculating Funds from Operations (“FFO”) per Diluted Share and Adjusted FFO per Diluted Share Results in Slightly Higher FFO per Diluted Share and Adjusted FFO per Diluted Share for Affected Periods NASHVILLE, Tenn., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE: RHP) (the “Company”), today announced that the Board of Directors has authorized, and the Company has declared, a third quarter cash dividend of $1.10 per share of common stock, to be paid on October 15...
electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference ROCKAWAY, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the 26th Annual H.C. Wainwright Global Investment Conference taking place in New York City on September 9-11, 2024. Dan Goldberger, the company’s Chief Executive Officer, will participate in a fireside chat on Wednesday, September 11th, at 12:00 PM ET. Mr. Goldberger will also be available for 1x1 meetin...
electroCore to Participate in Upcoming Investor Conferences ROCKAWAY, N.J., Aug. 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company’s CEO, Dan Goldberger, is scheduled to participate in the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference August 12 - 13, 2024. Please contact Needham to schedule a 1x1 meeting. In addition, Brian Posner, CFO of electroCore, Inc. is scheduled to attend the 44th Annual Canaccord Genuity Growth Conference taking place at InterContinental...
OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results Conference call begins at 4:30 p.m. Eastern time today MIAMI, Aug. 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2024. Highlights from the second quarter and recent weeks include the following: Enrollment underway in the MDX2001 Phase 1 trial for the treatment of solid tumor cancers. MDX2001, a tetraspecific antibody, is designed to optimize T-cell function to stimulate tumor regression while mini...
electroCore Announces Second Quarter 2024 Financial Results Seventh consecutive record quarterly net sales of $6.1 million, an increase of 73% over second quarter 2023 Company to host a conference call and webcast today, August 7, 2024 at 4:30 PM EST ROCKAWAY, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company and wellness company, today announced second quarter 2024 financial results. Recent Highlights •Net loss of $2.7 million, a decrease of 46% over second quarter 2023 •Launched our direct-to-consumer mobile ...
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) ROCKAWAY, N.J., Aug. 02, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that on August 1, 2024, Stephen Smith joined electroCore as the Company’s VP, Quality, Regulatory, and Compliance, and the Compensation Committee of electroCore’s Board of Directors granted 10,000 restricted stock units (“RSUs”) to Mr. Smith in connection with the commencement of his employment. The RSUs were granted as an inducement ma...
OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024 MIAMI, Aug. 01, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2024 after the close of the U.S. financial markets on Wednesday, August 7, 2024. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on August 7th beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participan...
CORRECTION -- Ryman Hospitality Properties, Inc. Reports Second Quarter 2024 Results This press release corrects a clerical error regarding the omission of pro rata adjustments from joint ventures and loss on extinguishment of debt in the reconciliation to net income of funds from operations and adjusted funds from operations in the prior version of the press release issued on July 31, 2024. There are no other changes to the prior version of the press release, and the amount of funds from operations and adjusted funds from operations for the periods presented remains unchanged from the prio...
Non-invasive Vagus Nerve Stimulation (nVNS) is effective at accelerating foreign language learning Clinical Trial demonstrates that nVNS is an effective learning acceleration tool while simultaneously improving focus and decreasing fatigue in study participants ROCKAWAY, N.J., Aug. 01, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that the Air Force Research Laboratories (AFRL) published a paper entitled “Transcutaneous Cervical Vagus Nerve Stimulation Enhances Second-Language Vocabulary Acquisi...
Ryman Hospitality Properties, Inc. Reports Second Quarter 2024 Results NASHVILLE, Tenn., July 31, 2024 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE: RHP), a lodging real estate investment trust (“REIT”) specializing in group-oriented, destination hotel assets in urban and resort markets, today reported financial results for the three and six months ended June 30, 2024. Second Quarter 2024 Highlights and Recent Developments: The Company generated record second quarter net income of $104.7 million and record second quarter net income available to common stockholders of $10...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.